Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia

This review (7 trials; n=759) suggests that discontinuing cholinesterase inhibitors may result in worse cognitive, neuropsychiatric and functional status than continuing treatment, although this is supported by limited evidence, almost all of low or very low certainty.

Source:

Cochrane Database of Systematic Reviews